Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy
/in Dendritic Cells, Hyperthermia, International Publications, Ovarian Cancer /von 2012-05-05 / Case Rep Oncol 2012 May;5(2):212-5Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-04-26 / Braz. J. Med. Biol. Res. 2012 Jun;45(6):510-5Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-44Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2012-04-05 / Cancer Immunol. Immunother. 2012 Nov;61(11):1929-39Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-04-02 / PLoS ONE 2012;7(4):e32614Cellular immunotherapy using dendritic cells against multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2012-03-28 / Korean J Hematol 2012 Mar;47(1):17-27Cancer immunotherapy via dendritic cells
/in Dendritic Cells, International Publications /von 2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):265-77Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-03-20 / Cancer Immunol. Immunother. 2012 Oct;61(10):1791-804Immunotherapy using dendritic cells against multiple myeloma: how to improve?
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2012-03-15 / Clin. Dev. Immunol. 2012;2012:397648
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de